Henderson John T. - 12 Sep 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Henderson
Issuer symbol
CYTK
Transactions as of
12 Sep 2022
Net transactions value
-$1,108,077
Form type
4
Filing time
12 Sep 2022, 16:27:02 UTC
Previous filing
12 Jul 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $29,145 +7,250 +30% $4.02* 31,299 12 Sep 2022 Direct F1
transaction CYTK Common Stock Sale $398,330 -7,250 -23% $54.94 24,049 12 Sep 2022 Direct F1
transaction CYTK Common Stock Options Exercise $29,145 +7,250 +30% $4.02* 31,299 12 Sep 2022 Direct F1
transaction CYTK Common Stock Sale $398,402 -7,250 -23% $54.95 24,049 12 Sep 2022 Direct F1
transaction CYTK Common Stock Options Exercise $29,181 +7,259 +30% $4.02* 31,308 12 Sep 2022 Direct F1
transaction CYTK Common Stock Sale $398,817 -7,259 -23% $54.94 24,049 12 Sep 2022 Direct F1
holding CYTK Common Stock 83 12 Sep 2022 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7,250 -33% $0.000000 14,509 12 Sep 2022 Common Stock 7,250 $4.02 Direct F1
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7,250 -50% $0.000000 7,259 12 Sep 2022 Common Stock 7,250 $4.02 Direct F1
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7,259 -100% $0.000000* 0 12 Sep 2022 Common Stock 7,259 $4.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 11, 2022.